Design and Synthesis of a 18 F‐Radiolabeled Pyrrolo[2,3‐ d ]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent
Journal of Labelled Compounds and Radiopharmaceuticals · 2025
DOI: 10.1002/jlcr.4131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2025. Verfasst von Srinivasulu Cherukupalli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Hauptthemen laut MEDLINE: Fluorine Radioisotopes, Positron-Emission Tomography, Pyrimidines, Pyrroles. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Trond Mohn Foundation, Research Council of Norway, Norwegian NMR Platform.
Abstract (Originalsprache)
Colony‐stimulating factor 1 receptor (CSF1R or c‐FMS), a class III receptor tyrosine kinase, is significantly expressed in mononuclear phagocytes and in the central nervous system. It has been identified as a potential drug and imaging target in numerous inflammatory, cancerous, and neurodegenerative diseases. Despite several attempts, no validated CSF1R PET tracer is currently available. Herein, we report the design and synthesis of a 18 F‐radiolabeled pyrrolo[2,3‐ d ]pyrimidine molecule based on previously developed potent and selective CSF1R inhibitors. Initially, a nonlabeled fluorinated compound was synthesized using conventional and microwave methods, and it exhibited potent CSF1R inhibitory activity (IC 50 = 6 nM). A tosylate precursor was then synthesized for subsequent radiofluorination. The 18 F‐radiolabeled compound was produced using K[ 18 F]F Kryptofix 222 (K 2.2.2 )‐carbonate in acetonitrile (10% DMF). The optimal labeling conditions, with a tosylate leaving group at 100°C for 5 min, resulted in the production of the 18 F‐radiolabeled pyrrolo[2,3‐ d ]pyrimidine CSF1R inhibitor with high purity and with a molar activity of the final product of 57 GBq/μmol. The synthesized inhibitor might open new possibilities for in vivo imaging in neuroinflammation and related disorders, and future studies will evaluate its performance as a PET tracer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
- Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
- Department of Material Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
ORCID-Profile: Eirik Sundby
Förderung
- Trond Mohn Foundation
- Research Council of Norway
- Norwegian NMR Platform
- Trond Mohn stiftelse
- Norges Forskningsråd
Zitieren
APA
Cherukupalli, S., Karlsen, M., Hoff, B. H., & Sundby, E. (2025). Design and Synthesis of a 18 F‐Radiolabeled Pyrrolo[2,3‐ d ]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4131
Vancouver
Cherukupalli S, Karlsen M, Hoff BH, Sundby E. Design and Synthesis of a 18 F‐Radiolabeled Pyrrolo[2,3‐ d ]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent. Journal of Labelled Compounds and Radiopharmaceuticals. 2025. doi:10.1002/jlcr.4131
BibTeX
@article{Cherukupalli2025,
author = {Cherukupalli, Srinivasulu and Karlsen, Morten and Hoff, Bård Helge and Sundby, Eirik},
title = {Design and Synthesis of a 18 F‐Radiolabeled Pyrrolo[2,3‐ d ]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2025},
doi = {10.1002/jlcr.4131}
}
EUVIMED